NAI Senior Consultant, Jill E. Sackman, D.V.M., Ph.D., continues her “Navigating Emerging Markets” column with BioPharm International in her piece concerning the regulatory trends in South Korea, published August 1, 2013.

Jill provides insight and guidance regarding trends in regulatory harmonization and pharmacovigilance, reimbursement, and regional considerations of South Korea that will directly influence successful market entry.

See the full article – Navigating Emerging Markets– South Korea.